Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-29.9%
operating margin TTM
-31.51%
revenue TTM
638.22 Million
revenue per share TTM
5.22$
valuation ratios | |
|---|---|
| pe ratio | -5.20 |
| peg ratio | -0.05 |
| price to book ratio | 1.34 |
| price to sales ratio | 1.58 |
| enterprise value multiple | -9.15 |
| price fair value | 1.34 |
profitability ratios | |
|---|---|
| gross profit margin | 68.73% |
| operating profit margin | -31.51% |
| pretax profit margin | -29.09% |
| net profit margin | -29.9% |
| return on assets | -19.88% |
| return on equity | -25.4% |
| return on capital employed | -24.03% |
liquidity ratio | |
|---|---|
| current ratio | 4.97 |
| quick ratio | 4.26 |
| cash ratio | 2.92 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 158.84 |
| operating cycle | 211.35 |
| days of payables outstanding | 24.67 |
| cash conversion cycle | 186.67 |
| receivables turnover | 6.95 |
| payables turnover | 14.79 |
| inventory turnover | 2.30 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | 0.12 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.10 |
| interest coverage | -48,114.75 |
| cash flow to debt ratio | 0.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.06 |
| cash per share | 3.27 |
| operating cash flow per share | 0.06 |
| free cash flow operating cash flow ratio | -1.01 |
| cash flow coverage ratios | 0.08 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.50 |
Frequently Asked Questions
When was the last time 10x Genomics, Inc. (NASDAQ:TXG) reported earnings?
10x Genomics, Inc. (TXG) published its most recent earnings results on 29-10-2024.
What is 10x Genomics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. 10x Genomics, Inc. (NASDAQ:TXG)'s trailing twelve months ROE is -25.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. 10x Genomics, Inc. (TXG) currently has a ROA of -19.88%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TXG's net profit margin stand at?
TXG reported a profit margin of -29.9% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TXG's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.97 in the most recent quarter. The quick ratio stood at 4.26, with a Debt/Eq ratio of 0.12.